Dedicated to the 10th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2019) (Ongoing)

Posted On 2020-01-18 07:39:14

This Focused Issue “Dedicated to the 10th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2019)” is edited by Dr. Mirella Marino from Regina Elena National Cancer Institute, Italy and Prof. Brett W. Carter from The University of Texas MD Anderson Cancer Center, USA. 

Dr. Marino is the referral Pathologist for Hematopathology and for Thymic Epithelial Tumors (TET) (diagnostics and research) at the IRCCS Regina Elena National Cancer Institute (IRE), Rome, Italy. After her medical doctoral degree in Rome, University “La Sapienza”, M. Marino was trained in Hematopathology/Thymic Pathology during short stages in Germany, at the Kiel Christian-Albrechts-Universität, Pathology Institute, leaded by Prof Dr K Lennert, and at the Julius-Maximilians-Universität, Würzburg, at the Pathology Institute leaded by Prof. Dr HK Müller Hermelink. In 1983 she was fellow of the Deutsches Akademisches Austauschdienst (DAAD) for a research project on TET at the Pathology Institute in Kiel. She contributed to the 2015 WHO TET classification, to the TCGA of Thymoma and to the TNM staging (8th edition) of TET.  Moreover, she is “HCP Domain representative” of IRE for the “Rare thoracic tumors” (G8) network in the European Reference Network (ERN).

M. Marino holds the membership and Committees contribution in the International Thymic Malignancy Interest Group (ITMIG), in the International Association of Study for Lung Cancer (IASLC), European Society of Pathology (ESP)(in Mediastinal and Thymus Working Group and in  History of Pathology WG); Italian Society of Pathological Anatomy (SIAPEC); she is Member of the IASLC Staging and Prognostic Factors Committee. M. Marino also serves on the editorial board of Case Reports in Pathology (Hindawi), of Journal of Thoracic Disease (JTD) and of Mediastinum (AME).

Dr. Brett W. Carter is an Associate Professor of Radiology at the University of Texas MD Anderson Cancer Center in Houston, Texas. He currently serves as Director of Thoracic CT, Co-Director of Thoracic MRI, Clinical Co-Director of the Quantitative Imaging Analysis Core (QIAC), Co-Director of the Imaging Response Assessment Team (IRAT), and Co-Chair of the Diagnostic Radiology Peer Review Committee (DRPRC). Dr. Carter is as an Associate Editor for the American College of Radiology’s Case-in-Point and BMC Medical Imaging. He is the author/co-author of over 70 publications, 90 abstracts, and 120 books chapters, and the editor of 3 books.

Dr. Carter has been the recipient of the American College of Radiology Imaging Network (ACRIN) Young Investigator Initiative Award, Radiological Society of North America (RSNA) Honored Educator Award, Distinguished Reviewer Award (American Journal of Roentgenology), Editors’ Recognition Award for Distinction in Reviewing (Journal of Thoracic Imaging), Editor’s Recognition Award with Special Distinction (RadioGraphics), over 20 awards for educational exhibits, and was selected for the 2016 Melvin M. Figley Fellowship in Radiology Journalism by the American Roentgen Ray Society (ARRS). Dr. Carter serves as Principal Investigator or Co-Investigator on over 50 clinical trials/protocols and has given numerous lectures at national and international conferences.

Focused issue outline:

1. Editorial
2. Thymoma: Unusual Morphology

Prodipto Pal, Department of Laboratory Medicine and Pathobiology, University of  Toronto, Toronto, ON, Canada; Department of Pathology, Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
3. What Kind of Beast is this beautiful Tumor?
Anja Roden, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA
4. A Childhood Thymoma
Alexander Marx, Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany
5. A Thymoma or Not a Thymoma – That is the Question
Malgorzata Szolkowska, Pathology Department, The National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland
6. When the Morphology Meets the Genomics
Mirella Marino, Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy
7. How the Thymus Shapes the Immune System
Kenneth Weinberg, Department of Pediatrics, Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University, Stanford, CA, USA
8. Unique Diagnostic Approach and Management of Myasthenia Gravis in the Context of a Thymic Tumor
Maria Da Silva Leite, Nuffield Department of Clinical Neurosciences, Oxford University Hospitals and University of Oxford, Oxford, UK
9. PRO Immunotherapy: Immunotherapy SHOULD be Used in Thymic Tumors
Arun Rajan, Thoracic and Gastrointestinal Malignancies Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
10. State of the Art - Best Expected Outcomes of Surgical Resection of Thymoma
Joshua Sonett, Division of Thoracic Surgery, Department of Surgery, Columbia University Medical Center, New York City, NY, USA
11. Current Assessment of Minimally Invasive Surgery in the Management of Thymoma
Alan Kirk, Department of Thoracic Surgery, Golden Jubilee National Hospital, Clydebank, UK
12. Indications for Adjuvant Radiation in Thymoma - and Who Should NOT Receive it
Andreas Rimner, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
13. Induction Chemo Radiation for Thymoma - Selection of Candidates
Sukhmani Padda, Division of Oncology, Department of Medicine, Stanford University School of Medicine and Stanford Cancer Institute, Stanford, CA, USA
14. Resection for Stage IV Thymoma - Surgical Approaches
Shaf Keshavjee, University Health Network, University of Toronto, Toronto, ON, Canada
15. ITMIG International Updates-Japan 
Meinoshin Okumura, Toneyama National Hospital, Osaka, Japan
16. ITMIG International Updates-Korea
Dong Kwan Kim, Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, Ulsan University College of Medicine, Seoul, Korea
17. Postoperative Radiation Therapy for Thymic Carcinoma – Analysis of the ITMIG/ESTS Database
Andreas Rimner, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
18. An Overview: Ongoing Systemic Therapy Trials Around the World - Will Anything “Hit”?
Claire Merveilleux du Vignaux, University of Lyon, University Claude Bernard Lyon 1, Lyon, France; Respiratory Medicine Department, Hospices Civils de Lyon, Lyon, France
19. Surgery Clinical Trials – Challenges in a Rare Disease
Joshua Sonett, Division of Thoracic Surgery, Department of Surgery, Columbia University Medical Center, New York City, NY, USA
20. What Radiation Dose do we Need to Deliver?
Anthony Brade, Carlo Fidani Regional Cancer Centre / Credit Valley Hospital, Canada
21. What Radiation Techniques can we use to Optimize Target Coverage and Minimize Toxicity?
Charles Simone, New York Proton Center, NY, USA


Disclosure:
The series “Dedicated to the 10th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2019)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding. Mirella Marino and Brett Carter are serving as the unpaid Guest Editors for the series.